The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index; none of the 91 sources its claims cite is checked for support yet.
Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in Men
Open accessAbstract
Trichomonas vaginalis infections in men are traditionally considered to be benign and consequently have been overlooked. However, men with this common sexually transmitted infection can experience urethritis, prostatitis, reduced fertility, and amplified human immunodeficiency virus risk. In addition, men are often asymptomatic and can unknowingly spread the infection to their female sexual partners. With advances in T. vaginalis diagnostics, more men are being diagnosed, yet the optimal method of treatment in men remains unknown. The purpose of this review is to discuss the epidemiology, natural history, diagnosis, and treatment of T. vaginalis among men.
Overview
CoChat Summary
TL;DR
This review summarizes the epidemiology, natural history, diagnosis, and treatment of *Trichomonas vaginalis* in men, emphasizing that male infections are common, often asymptomatic, and underdiagnosed. It concludes that the optimal treatment regimen in men remains unknown and calls for better natural history and treatment data.
Key findings
- In 2016, WHO estimated global *T. vaginalis* prevalence at 5.0% in women and 0.6% in men, with male prevalence ranging from 0.2% to 1.3% and highest rates in Africa and the Americas. In the United States, male incidence was estimated at 4.1 million infections in 2018, and NHANES 2013–2014 estimated prevalence in men aged 18–59 years at 0.5% versus 1.8% in women.
- Up to 72% of male sexual partners of infected women can also be infected. In one US study of 177 men with trichomoniasis-infected female partners, 136 (76.8%) were infected but asymptomatic; among symptomatic men, penile discharge was most commonly reported.
- NAATs are now the gold standard: Xpert TV assay showed 97.2% sensitivity and 99.9% specificity; Cobas TV/MG assay 100% sensitivity and 98.4% specificity; BDMax CTGCTV2 assay 97.9% sensitivity and 99.7% specificity. Culture sensitivity was 40–56% with 100% specificity, and wet-mount microscopy was 25–40% sensitive and not recommended for men. Penile meatal swabs had 80.4% sensitivity versus 39.3% for urine in one home-testing study, and 85% sensitivity/96.7% specificity versus clinician-collected urethral swabs; 86% of men in one study preferred self-collected penile swabs.
- Treatment data in men are limited: in a Russian study of 210 men given 2 g metronidazole (MTZ), cure was 57.6%; in a Zimbabwean study, only 42.9% of 38 men given 2 g MTZ cleared infection, whereas all 287 men given 400 mg MTZ three times daily for 5 days cleared infection. In a Japanese study, 1 g tinidazole and 1.5 g MTZ both yielded 100% negative cultures at 14 and 30 days; in an Egyptian study, all 85 men treated with ornidazole, MTZ, or secnidazole tested negative.
Methods
- Design: narrative review of the epidemiology, natural history, diagnosis, and treatment of *T. vaginalis* in men.
- Data: published literature, CDC treatment guidelines, and tables summarizing diagnostic tests and treatment studies in men; no primary data were collected.
- Analysis: qualitative synthesis of existing studies and guidelines; no systematic search strategy or meta-analysis is described.
Limitations
- Stated in the paper: natural history studies in men are limited and difficult to conduct because men are often asymptomatic; the optimal treatment method in men remains unknown; no data exist on MTZ resistance in men; most trichomoniasis research has been conducted in women; and routine screening is not currently recommended by the CDC.
- Stated in the paper: current treatment recommendations for men have largely been extrapolated from studies in women, and an adequately powered head-to-head comparison of 2 g MTZ versus multidose MTZ in men is needed.
- Evident from the text: as a narrative review, it reports no systematic search strategy, inclusion criteria, or formal risk-of-bias assessment, and many cited studies are small, old, or placed in supplementary references.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 69 Not checked · 10 Own results and interpretations
In the paper
“routine screening of both women and men for T. vaginalis is not currently recommended by the Centers for Disease Control and Prevention (CDC) [20].”
What the sources say
- Not checked yetcites [20] Workowski, 2015, Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines, Clin Infect Dis source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, 5 (36%) of the men experienced spontaneous resolution of infection at an average of 16 ± 12 days after diagnosis.”
What the sources say
- Not checked yetcites [39] Krieger, 1993, Natural history of urogenital trichomoniasis in men, J Urol source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The 5-nitroimidazoles (metronidazole [MTZ], tinidazole [TDZ], secnidazole [SEC]) are the only class of antimicrobials effective against T. vaginalis .”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Trichomonas vaginalis is a rare cause of urethral and/or rectal infection among men who have sex with men (MSM).”
What the sources say
- Not checked yetcites [32] van der Veer, 2016, Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands, Sex Transm Infect source
- Not checked yetcites [33] Kelley, 2012, Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men, Sex Transm Dis source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Among the minority of symptomatic men in this study, penile discharge was most commonly reported [19].”
What the sources say
- Not checked yetcites [19] Seña, 2007, Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention, Clin Infect Dis source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
44 more claims
Create a free account to see all 80 claims and to verify the 51 references still open.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 9
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ TREATMENT
“of the 287 men given 400 mg MTZ 3 times daily for 5 days, all cleared infection”
§ TREATMENT
“38 received single-dose MTZ and 15 received MTZ 400 mg × 5 days”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in Men
“Since up to 72% of male sexual partners of infected women can also be infected [19]”
§ NATURAL HISTORY
“In 1 US study, 177 men with trichomoniasisinfected female sexual partners were assessed and 136 (76.8%) were infected but asymptomatic.”
Citations
Cites
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
Rowley, J., Vander Hoorn, S., Korenromp, E., Low, N., Unemo, M., Abu-Raddad, L. J., Chico, R. M., Smolak, A., Newman, L., Gottlieb, S., et al. (2019) · Bulletin of the World Health Organization · doi:10.2471/blt.18.228486 · Cited by 1,665
Systemic racism and U.S. health care
Feagin, J., & Bennefield, Z. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.09.006 · Cited by 819
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ771 · Cited by 588
Moodley, P., Wilkinson, D., Connolly, C., Moodley, J., & Sturm, A. W. (2002) · Clinical Infectious Diseases · doi:10.1086/338399 · Cited by 284
Trichomonas vaginalis, HIV, and African-Americans
Sorvillo, F., Smith, L., Kerndt, P., & Ash, L. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0706.010603 · Cited by 266
Trichomonas vaginalis as a Cause of Perinatal Morbidity: A Systematic Review and Meta-Analysis
Silver, B. J., Guy, R. J., Kaldor, J. M., Jamil, M. S., & Rumbold, A. R. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000134 · Cited by 252
Trichomoniasis and HIV interactions: a review
Kissinger, P., & Adamski, A. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-051005 · Cited by 237
Self-citationSena, A. C., Miller, W. C., Hobbs, M. M., Schwebke, J. R., Leone, P. A., Swygard, H., Atashili, J., & Cohen, M. S. (2007) · Clinical Infectious Diseases · doi:10.1086/511144 · Cited by 236
Schwebke, J. R., Rompalo, A., Taylor, S., Sena, A. C., Martin, D. H., Lopez, L. M., Lensing, S., & Lee, J. Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq074 · Cited by 235
Cited by
Sexually transmitted infections and female reproductive health
Van Gerwen, O. T., Muzny, C. A., & Marrazzo, J. M. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01177-x · Cited by 224
Self-citationGerwen, O. T. V., Opsteen, S., Graves, K. J., & Muzny, C. A. (2023) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2023.02.001 · Cited by 84
Self-citationMultiple pathogens and prostate cancer
Lawson, J. S., & Glenn, W. K. (2022) · Infectious Agents and Cancer · doi:10.1186/s13027-022-00427-1 · Cited by 60
Rada, P., Hrdý, I., Zdrha, A., Narayanasamy, R. K., Smutná, T., Horáčková, J., Harant, K., Beneš, V., Ong, S.-C., Tsai, C.-Y., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.893692 · Cited by 37
Dubé‐Zinatelli, E., Cappelletti, L., & Ismail, N. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.70026 · Cited by 34
Metadata
- Authors
- Van Gerwen, O. T., Camino, A. F., Sharma, J., Kissinger, P. J., & Muzny, C. A.
- Affiliations
- Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
- University of Alabama (US)
- University of Alabama at Birmingham (US)
- Tulane University (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-07-04
- Volume
- 73
- Issue
- 6
- Pages
- 1119-1124
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC8522801
- OpenAlex
- W3164421300
- Cited by
- 81
- References
- 42
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 24 · 2023: 15 · 2022: 12 · 2021: 1
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Agency of Healthcare Research and Quality (T32HS013852)
- National Center for Advancing Translational Sciences
- National Institutes of Health (TL1TR003106)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
- Keywords
- Trichomonas vaginalis, trichomoniasis, men, sexually transmitted infections, urethritis, prostatitis, male fertility, HIV risk, asymptomatic infection, epidemiology, natural history (disease), diagnosis, treatment
- MeSH terms
- Humans, Male, Sexual Partners, Sexually Transmitted Diseases, Trichomonas Infections, Trichomonas vaginalis, Urethritis, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.